Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 8 of 8 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/11/20
End: 10/12/21
Due: 10/12/22
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 02/13/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 09/19/18
End: 03/14/25
Due: 03/14/26
Phase: N/A
Priority: Normal
Start: 02/08/19
End: 03/14/25
Due: 03/14/26
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 05/02/23
Due: 05/02/24
Phase: N/A
Priority: Normal
Start: 11/03/23
End: 07/30/30
Due: 07/30/31
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Calypso Knee System Clinical Sub-study, OUS Continued Evaluation | NCT04548882 | Moximed | user2@example.com | None | 2020-09-11 | 2021-10-12 | 2022-10-12 | - | - | 2025-07-14 |
| European Post-Market Study for Medial Knee Osteoarthritis Treated With the Atlas Knee System for Load Reduction | NCT02663414 | Moximed | user2@example.com | None | 2016-03-31 | 2018-11-30 | 2019-11-30 | - | - | 2025-07-14 |
| MOTION Clinical Trial | NCT06843980 | Moximed | user2@example.com | None | 2025-02-13 | 2029-12-31 | 2030-12-31 | - | - | 2025-07-14 |
| KineSpring® System Patient Preference Study | NCT02934672 | Moximed | user2@example.com | None | 2016-06-30 | 2016-06-30 | 2017-06-30 | - | - | 2025-07-14 |
| Calypso Knee System Clinical Study | NCT03671213 | Moximed | user2@example.com | None | 2018-09-19 | 2025-03-14 | 2026-03-14 | - | - | 2025-07-14 |
| Calypso Knee System Clinical Study, OUS | NCT03838978 | Moximed | user2@example.com | None | 2019-02-08 | 2025-03-14 | 2026-03-14 | - | - | 2025-07-14 |
| Atlas Knee System Clinical System Clinical Study (USA) | NCT02934659 | Moximed | user2@example.com | None | 2016-11-30 | 2023-05-02 | 2024-05-02 | - | - | 2025-07-14 |
| MISHA Post-Market Clinical Study | NCT06118892 | Moximed | user2@example.com | None | 2023-11-03 | 2030-07-30 | 2031-07-30 | - | - | 2025-07-14 |